Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Armigliato, M.
Right arrow Articles by Cella, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armigliato, M.
Right arrow Articles by Cella, G.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Pulmonary Hypertension
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Hyperthyroidism as a Cause of Pulmonary Arterial Hypertension: A Prospective Study

Michela Armigliato, MD

Departments of Medicine, University of Padova Medical School, Padova, Italy, Rovigo and Padova, Italy

Rossella Paolini, MD

Departments of Medicine, University of Padova Medical School, Padova, Italy, Rovigo and Padova, Italy

Silvio Aggio, MD

Cardiology, Rovigo General Hospital, Rovigo University of Padova Medical School, Padova, Italy, Rovigo and Padova, Italy

Sergio Zamboni, MD

Departments of Medicine, University of Padova Medical School, Padova, Italy, Rovigo and Padova, Italy

Maria Paola Galasso, MD

Cardiology, Rovigo General Hospital, Rovigo University of Padova Medical School, Padova, Italy, Rovigo and Padova, Italy

Pietro Zonzin, MD

Cardiology, Rovigo General Hospital, Rovigo University of Padova Medical School, Padova, Italy, Rovigo and Padova, Italy

Giuseppe Cella, MD

Department of Medical and Surgical Sciences, University of Padova Medical School, Padova, Italy, Rovigo and Padova, Italy, giuseppe.cella{at}unipd.it

The authors assessed the prevalence of pulmonary arterial hypertension (PAH) in patients with hyperthyroidism and evaluated the response to treatment of the thyrotoxicosis. They assessed the pulmonary artery systolic pressure (PASP) at rest (estimated by echocardiography) in 23 consecutive patients diagnosed with hyperthyroidism due to Graves’ disease or toxic multinodular goiter. Twelve of 23 patients (52%) did not show antithyroglobulin and antithyroperoxidase antibodies. Seventeen patients were followed up for at least 9 months after achieving a stable euthyroid status. Fifteen (65%) patients demonstrated PAH at admission. Four patients were lost to follow-up; therefore they were able to evaluate 17 patients serially with echocardiography. Sixteen patients normalized their PASP value: 13 after methimazole, 2 after total thyroidectomy, and 1 after 131I treatment. In 1 patient no significant change in PASP was observed. This patient experienced an acute myocardial reinfarction during follow-up. They found a higher prevalence than that previously reported in observational studies. In addition, they demonstrated that the PAH reverses after correction of hyperthyroidism. Elevated PASP at rest on echocardiography may be considered a frequent finding of thyrotoxicosis. Moreover, the data seem not to support an autoimmune pathogenesis for PAH.

Angiology, Vol. 57, No. 5, 600-606 (2006)
DOI: 10.1177/0003319706293131


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement